TOP > 外国特許検索 > COLLAGEN FUSION PROTEIN AND DRUG SCREENING METHOD USING SAME

COLLAGEN FUSION PROTEIN AND DRUG SCREENING METHOD USING SAME 新技術説明会

外国特許コード F160008899
整理番号 (S2015-0733-N0)
掲載日 2016年11月11日
出願国 世界知的所有権機関(WIPO)
国際出願番号 2016JP059066
国際公開番号 WO 2016152882
国際出願日 平成28年3月22日(2016.3.22)
国際公開日 平成28年9月29日(2016.9.29)
優先権データ
  • 特願2015-057688 (2015.3.20) JP
発明の名称 (英語) COLLAGEN FUSION PROTEIN AND DRUG SCREENING METHOD USING SAME 新技術説明会
発明の概要(英語) The purpose of the present invention is to construct a system whereby secretion of procollagen from an animal cells can be detected. This purpose can be achieved by a fusion protein of a fluorescent protein or luminescent protein and a collagen-related protein which is a collagen protein, a procollagen protein, a preprocollagen protein having a repeating amino acid sequence of Gly-Xaa-Yaa (where Gly represents glycine and Xaa and Yaa represent arbitrary amino acids), or a variant or fragment thereof.
従来技術、競合技術の概要(英語) BACKGROUND ART
Collagen, protein 30% occupies in the living body, and cell adhesion skeletal support important proteins and have functions such as, for example, human body bone, cartilage, ligament, tendon, cornea, skin, liver, muscle tissue such as the major constituents. Is collagen, fibrous collagen collagen to form fibrils, in a non - fibrillar collagen does not form fibrils present. Fibrous collagen, the polypeptide chains of the collagen triple helical structure is present 3 3 (tropocollagen) gather to form. 3 Is the double helix structure of the topo collagen, by self-assemble, shifted by 1/4 molecular length alignment, (fibrillar collagen) collagen fibrils to form. Further, this collagen fibrils, and merge the many, collagen fibers (collagen fiber bundles) to form. Further, in the corneal stroma and cortical bone, collagen fibers aligned in the same direction to form a two-dimensional layers, each layer 1 this layer is further laminated veneer-like and then a three-dimensional layer that takes the plate structure. This veneer-like three-dimensional layer board structure is collagen, are transparent and have a high strength.
Of such a collagen molecular abnormalities caused by collagen diseases (for example, dermatomyositis, polymyositis) or corneal cloudiness and the like, a method of treatment has not been established in many cases. This is, collagen secretion of an as-yet and the higher-order structure formation processes in the course also, one cause of 1. And the higher-order structure of collagen secretion analysis step of forming the course can be performed if, due to the collagen molecular abnormalities of clarification of the cause of the disease, and in the development of therapeutic thereof also can be used as an effective means.
  • 出願人(英語)
  • ※2012年7月以前掲載分については米国以外のすべての指定国
  • TOKYO INSTITUTE OF TECHNOLOGY
  • 発明者(英語)
  • TANAKA Toshiaki
  • IKOMA Toshiyuki
  • TANAKA Junzo
国際特許分類(IPC)
指定国 National States: AE AG AL AM AO AT AU AZ BA BB BG BH BN BR BW BY BZ CA CH CL CN CO CR CU CZ DE DK DM DO DZ EC EE EG ES FI GB GD GE GH GM GT HN HR HU ID IL IN IR IS JP KE KG KN KP KR KZ LA LC LK LR LS LU LY MA MD ME MG MK MN MW MX MY MZ NA NG NI NO NZ OM PA PE PG PH PL PT QA RO RS RU RW SA SC SD SE SG SK SL SM ST SV SY TH TJ TM TN TR TT TZ UA UG US UZ VC VN ZA ZM ZW
ARIPO: BW GH GM KE LR LS MW MZ NA RW SD SL SZ TZ UG ZM ZW
EAPO: AM AZ BY KG KZ RU TJ TM
EPO: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
OAPI: BF BJ CF CG CI CM GA GN GQ GW KM ML MR NE SN ST TD TG
詳しくお知りになりたい方は下記「問合せ先」まで直接お問合わせください

PAGE TOP

close
close
close
close
close
close